Document is current
Any future updates will be listed below
-
Authors
Lu, Xiaozhao
Wei, Pan
Tang, Shangyi
Ye, Weitao
Huang, Zuxian
Yuan, Ziyao
Ruan, Huangtao
Huang, Haozhang
Zhang, Weipeng
Wang, Chenyang
Kang, Yu
Hu, Jing
Li, Zeliang
Deng, Jingru
Li, Yingying
Wu, Wanying
Ming, Wai-kit
Wong, Chun-Ka
Tan, Ning
Chen, Shiqun
Liu, Jin
Chen, Jiyan
Liu, Yong
-
Funding
Funding for this research was provided by:
Guangdong Medical Research Foundation (A2024065)
National Natural Science Foundation of China (82470531, 82270339)
Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention (Z022017016)
Guangdong Basic and Applied Basic Research Foundation (2022A1515012126)
AstraZeneca Externally Sponsored Research Project (ESR-23-22118)
Noncommunicable Chronic Diseases-National Science and Technology Major Project (2024ZD0532700)
- License Information
-
More Information
Article History
Received: 14 June 2025
Accepted: 10 October 2025
First Online: 12 November 2025
Declarations
:
: This study was conducted in accordance with the principles outlined in the Declaration of Helsinki. The study was reviewed and approved by the Ethics Committee of Guangdong Provincial People’s Hospital (Approval Number: GDREC2019-555 H-2). The follow-up information was collected by trained medical personnel who contacted patients or their family members by telephone or was obtained by matching the Centers for Disease Control and Prevention. All participants provided oral informed consent.
: All authors agree to publish the article.
: The authors declare no competing interests.
